Your browser doesn't support javascript.
loading
Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia.
Yashar, William M; Curtiss, Brittany M; Coleman, Daniel J; VanCampen, Jake; Kong, Garth; Macaraeg, Jommel; Estabrook, Joseph; Demir, Emek; Long, Nicola; Bottomly, Daniel; McWeeney, Shannon K; Tyner, Jeffrey W; Druker, Brian J; Maxson, Julia E; Braun, Theodore P.
Afiliação
  • Yashar WM; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Curtiss BM; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.
  • Coleman DJ; Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon.
  • VanCampen J; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Kong G; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.
  • Macaraeg J; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Estabrook J; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Demir E; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.
  • Long N; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Bottomly D; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.
  • McWeeney SK; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Tyner JW; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.
  • Druker BJ; Cancer Early Detection Advanced Research Center, Oregon Health & Science University, Portland, Oregon.
  • Maxson JE; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.
  • Braun TP; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon.
Mol Cancer Res ; 21(7): 631-647, 2023 07 05.
Article em En | MEDLINE | ID: mdl-36976323

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Tirosina Quinase 3 Semelhante a fms Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Tirosina Quinase 3 Semelhante a fms Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article